Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cannabis-based Medicines market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Cannabis-based Medicines industry. Based on our recent survey, we have several different scenarios about the Cannabis-based Medicines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Cannabis-based Medicines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cannabis-based Medicines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cannabis-based Medicines market in terms of revenue. Players, stakeholders, and other participants in the global Cannabis-based Medicines market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026. Regional and Country-level Analysis The report offers an exhaustive geographical analysis of the global Cannabis-based Medicines market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026. Competition Analysis In the competitive analysis section of the report, leading as well as prominent players of the global Cannabis-based Medicines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cannabis-based Medicines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cannabis-based Medicines market. The following players are covered in this report: GW Pharmaceuticals plc INSYS Therapeutics Aequus Pharmaceuticals Axim Biotechnologies Revive Therapeutics MGC Pharmaceuticals ECHO Pharmaceuticals ... Cannabis-based Medicines Breakdown Data by Type CBD (Cannabidiol) Based THC (Tetrahydrocannabinol) Based Others Cannabis-based Medicines Breakdown Data by Application Oral Solution Tablets Patches Others
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Cannabis-based Medicines Revenue 1.4 Market Analysis by Type 1.4.1 Global Cannabis-based Medicines Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 CBD (Cannabidiol) Based 1.4.3 THC (Tetrahydrocannabinol) Based 1.4.4 Others 1.5 Market by Application 1.5.1 Global Cannabis-based Medicines Market Share by Application: 2020 VS 2026 1.5.2 Oral Solution 1.5.3 Tablets 1.5.4 Patches 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): Cannabis-based Medicines Industry Impact 1.6.1 How the Covid-19 is Affecting the Cannabis-based Medicines Industry 1.6.1.1 Cannabis-based Medicines Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19?s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Cannabis-based Medicines Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Cannabis-based Medicines Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Cannabis-based Medicines Market Perspective (2015-2026) 2.2 Cannabis-based Medicines Growth Trends by Regions 2.2.1 Cannabis-based Medicines Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Cannabis-based Medicines Historic Market Share by Regions (2015-2020) 2.2.3 Cannabis-based Medicines Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter?s Five Forces Analysis 2.3.5 Cannabis-based Medicines Market Growth Strategy 2.3.6 Primary Interviews with Key Cannabis-based Medicines Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Cannabis-based Medicines Players by Market Size 3.1.1 Global Top Cannabis-based Medicines Players by Revenue (2015-2020) 3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2015-2020) 3.1.3 Global Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Cannabis-based Medicines Market Concentration Ratio 3.2.1 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Cannabis-based Medicines Revenue in 2019 3.3 Cannabis-based Medicines Key Players Head office and Area Served 3.4 Key Players Cannabis-based Medicines Product Solution and Service 3.5 Date of Enter into Cannabis-based Medicines Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Cannabis-based Medicines Historic Market Size by Type (2015-2020) 4.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2021-2026) 5 Cannabis-based Medicines Breakdown Data by Application (2015-2026) 5.1 Global Cannabis-based Medicines Market Size by Application (2015-2020) 5.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Cannabis-based Medicines Market Size (2015-2020) 6.2 Cannabis-based Medicines Key Players in North America (2019-2020) 6.3 North America Cannabis-based Medicines Market Size by Type (2015-2020) 6.4 North America Cannabis-based Medicines Market Size by Application (2015-2020) 7 Europe 7.1 Europe Cannabis-based Medicines Market Size (2015-2020) 7.2 Cannabis-based Medicines Key Players in Europe (2019-2020) 7.3 Europe Cannabis-based Medicines Market Size by Type (2015-2020) 7.4 Europe Cannabis-based Medicines Market Size by Application (2015-2020) 8 China 8.1 China Cannabis-based Medicines Market Size (2015-2020) 8.2 Cannabis-based Medicines Key Players in China (2019-2020) 8.3 China Cannabis-based Medicines Market Size by Type (2015-2020) 8.4 China Cannabis-based Medicines Market Size by Application (2015-2020) 9 Japan 9.1 Japan Cannabis-based Medicines Market Size (2015-2020) 9.2 Cannabis-based Medicines Key Players in Japan (2019-2020) 9.3 Japan Cannabis-based Medicines Market Size by Type (2015-2020) 9.4 Japan Cannabis-based Medicines Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Cannabis-based Medicines Market Size (2015-2020) 10.2 Cannabis-based Medicines Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Cannabis-based Medicines Market Size by Type (2015-2020) 10.4 Southeast Asia Cannabis-based Medicines Market Size by Application (2015-2020) 11 India 11.1 India Cannabis-based Medicines Market Size (2015-2020) 11.2 Cannabis-based Medicines Key Players in India (2019-2020) 11.3 India Cannabis-based Medicines Market Size by Type (2015-2020) 11.4 India Cannabis-based Medicines Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Cannabis-based Medicines Market Size (2015-2020) 12.2 Cannabis-based Medicines Key Players in Central & South America (2019-2020) 12.3 Central & South America Cannabis-based Medicines Market Size by Type (2015-2020) 12.4 Central & South America Cannabis-based Medicines Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 GW Pharmaceuticals plc 13.1.1 GW Pharmaceuticals plc Company Details 13.1.2 GW Pharmaceuticals plc Business Overview and Its Total Revenue 13.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Introduction 13.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2015-2020)) 13.1.5 GW Pharmaceuticals plc Recent Development 13.2 INSYS Therapeutics 13.2.1 INSYS Therapeutics Company Details 13.2.2 INSYS Therapeutics Business Overview and Its Total Revenue 13.2.3 INSYS Therapeutics Cannabis-based Medicines Introduction 13.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020) 13.2.5 INSYS Therapeutics Recent Development 13.3 Aequus Pharmaceuticals 13.3.1 Aequus Pharmaceuticals Company Details 13.3.2 Aequus Pharmaceuticals Business Overview and Its Total Revenue 13.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Introduction 13.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) 13.3.5 Aequus Pharmaceuticals Recent Development 13.4 Axim Biotechnologies 13.4.1 Axim Biotechnologies Company Details 13.4.2 Axim Biotechnologies Business Overview and Its Total Revenue 13.4.3 Axim Biotechnologies Cannabis-based Medicines Introduction 13.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2015-2020) 13.4.5 Axim Biotechnologies Recent Development 13.5 Revive Therapeutics 13.5.1 Revive Therapeutics Company Details 13.5.2 Revive Therapeutics Business Overview and Its Total Revenue 13.5.3 Revive Therapeutics Cannabis-based Medicines Introduction 13.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2015-2020) 13.5.5 Revive Therapeutics Recent Development 13.6 MGC Pharmaceuticals 13.6.1 MGC Pharmaceuticals Company Details 13.6.2 MGC Pharmaceuticals Business Overview and Its Total Revenue 13.6.3 MGC Pharmaceuticals Cannabis-based Medicines Introduction 13.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) 13.6.5 MGC Pharmaceuticals Recent Development 13.7 ECHO Pharmaceuticals 13.7.1 ECHO Pharmaceuticals Company Details 13.7.2 ECHO Pharmaceuticals Business Overview and Its Total Revenue 13.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Introduction 13.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2015-2020) 13.7.5 ECHO Pharmaceuticals Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
